Filed before 2025Filed 12 June 2020
Athira Pharma, Inc. raised $89M
Athira Pharma, Inc., a biotech company based in Seattle, WA, raised $89M in a new equity round, according to a filing dated 12 June 2020.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 12 June 2020
- Round
- Equity round
- Amount sold
- $89M
- Offering size
- $90.9M
- Investors so far
- 73
- Based in
- Seattle, WA
Investors on the board
- Perceptive Xontogeny
- Perceptive Xontogeny Venture SLP
- Perceptive Xontogeny Venture II SLP
- Arch River Navigator
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 94% of the 1,744 tracked raises with an amount filed in 2020, and than 88% of the 152 in biotech.
Athira Pharma, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 12 Jun 2020 | New filing | $89M | This raise |
| 24 Jan 2020 | Amended filing | $3.82M | Another raise |
| 19 Sep 2019 | Amended filing | $2.15M | Another raise |
| 23 Jan 2019 | Amended filing | $1.27M | Another raise |
| 20 Dec 2018 | New filing | $1.27M | Another raise |
Other unannounced rounds
- Thoughtform, Inc.$6.6M
- ProvenAir Technologies, Inc.$488K
- Gravitics, Inc.$17M
- SurgiBox Inc.$486K
- Voxel Labs Inc.$10M
- DVx Atomic Co.$18.5M
Seen it announced?
Send the link and the check will look at it.